Objective:
The guide aims to help cataract and refractive surgeons identify and manage ocular surface disease throughout the surgical journey.
Approach:
- Clinical care: “The Read” covers preoperative screening, selecting treatment based on disease, patient conversations, and postoperative care.
- Practice implementation: “The Rollout” addresses demonstrating the value of ocular surface care, building a team, and gaining staff buy-in.
- Content and tools: The guide draws on insights from five surgeons and findings from six studies, and includes six tear-out tools for clinical use.
Key Findings:
- Lumenis unveiled “Preventing 20/Unhappy: A Field Guide for Cataract and Refractive Surgeons” at the 2026 American Academy of Ophthalmology annual meeting in New Orleans.
- The guide includes guidance on treatment planning, matching treatment to disease severity, and determining surgical readiness.
- The article identifies OptiLIGHT, an intense pulsed light device, as FDA-approved for dry eye management due to meibomian gland dysfunction.
Interpretation:
According to Lumenis, the resource combines current research, clinical insights, and practical strategies for incorporating ocular surface care into existing workflows.
Limitations:
- The provided article context does not report clinical outcomes or independently evaluate the guide.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.